Drug intelligence / Profile preview

Fomes officinalis extract

Development stage
Preclinical
Lead developer
BASF
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Topical
01

Overview

Fomes officinalis extract (also known as Agarikon extract) is a botanical extract derived from the pulp of the *Fomes officinalis* (or *Laricifomes officinalis*) mushroom, a bracket fungus that grows on larch and conifer trees. It is widely used as a cosmetic and personal care ingredient for its astringent, pore-tightening, and sebum-regulating properties. In dermatological applications, the extract acts as an adaptive sebum modulator, suppressing excessive sebum secretion while maintaining basal lipid production [1.1]. This is achieved through the upregulation of microRNA-29 (miR-29), which downregulates the SCAP/SREBP-1 lipogenic cascade (including SREBP-1, SCAP, ACC, FASN, and PPAR-γ) [1.1]. It is developed by companies such as Simcare Biotechnology Group and supplied by ingredient manufacturers like BASF and Cobiosa for use in topical skincare formulations targeting oily, combination, and sensitive skin, as well as acne vulgaris.

Brand names
Laricyl BC 10206Laricyl LS 8865Pore ReductylPore Reductyl NT
Other names
Agarikon extractFomes officinalis (mushroom) extractFomes officinalis, ext.Laricifomes officinalis extractLarch Agaric extractWhite Agaric extract
02

Targets

ACC (Acetyl-CoA Carboxylase 1)ANT1/2/3 (Mitochondrial ADP/ATP translocase)FASN (Fatty acid synthase)PPARG (Peroxisome proliferator-activated receptor gamma)SCAP (SREBP cleavage-activating protein)SREBP-1 / SREBF1 (SREBP-1)miR-29 (MicroRNA-29)

Beyond the preview

Go deeper on Fomes officinalis extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fomes officinalis extract.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call